Elon Musk’s brain-chip startup Neuralink has successfully implanted its brain-computer interface (BCI) in a human patient for the first time, and the individual is reportedly recovering well. Elon Musk announced the milestone on social media, stating that initial results show promising neuron spike detection. The U.S. Food and Drug Administration (FDA) granted Neuralink clearance last year to conduct its first human trial, marking a crucial step in the company’s mission to assist patients with paralysis and neurological conditions. Neuralink’s BCI implant aims to allow people to control a computer cursor or keyboard using their thoughts. The first product from Neuralink is named Telepathy. The startup’s PRIME Study, evaluating the safety of the implant and surgical robot, is currently underway. However, Neuralink has faced scrutiny over safety protocols and was fined for violating U.S. Department of Transportation rules. In November, lawmakers requested an investigation into whether Musk misled investors about the technology’s safety, citing issues observed in monkey implants. Musk has previously stated that no monkeys died as a result of Neuralink implants.
Source – CGTN